Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership150,778 shares
Latest Disclosed Value $ 800,631
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in MYGN / Myriad Genetics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 150,778 shares of Myriad Genetics, Inc. (US:MYGN) valued at $800,631 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 150,778 shares of Myriad Genetics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $689,055 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Myriad Genetics EC US62855J1043 150,778 0 0.00 801 -40.16 0.0180
2025-05-28 2025-03-31 NP Myriad Genetics EC US62855J1043 150,778 0 0.00 1,337 -35.32 0.0321
2025-02-25 2024-12-31 NP Myriad Genetics EC US62855J1043 150,778 -24,585 -14.02 2,067 -56.96 0.0451
2024-11-26 2024-09-30 NP Myriad Genetics EC US62855J1043 175,363 9,472 5.71 4,803 18.39 0.0908
2024-08-26 2024-06-30 NP Myriad Genetics EC US62855J1043 165,891 12,163 7.91 4,058 23.80 0.0826
2024-05-28 2024-03-31 NP Myriad Genetics EC US62855J1043 153,728 7,679 5.26 3,277 17.25 0.0684
2024-02-26 2023-12-31 NP Myriad Genetics EC US62855J1043 146,049 9,056 6.61 2,795 27.22 0.0597
2023-11-28 2023-09-30 NP Myriad Genetics EC US62855J1043 136,993 -2,686 -1.92 2,197 -32.13 0.0573
2023-08-25 2023-06-30 NP Myriad Genetics EC US62855J1043 139,679 13,337 10.56 3,238 10.33 0.0768
2023-05-26 2023-03-31 NP Myriad Genetics EC US62855J1043 126,342 871 0.69 2,935 61.21 0.0782
2023-02-24 2022-12-31 NP Myriad Genetics EC US62855J1043 125,471 -2,248 -1.76 1,821 -25.29 0.0501
2022-11-25 2022-09-30 NP Myriad Genetics EC US62855J1043 127,719 0 0.00 2,437 5.00 0.0698
2022-08-25 2022-06-30 NP Myriad Genetics EC US62855J1043 127,719 3,966 3.20 2,321 -25.59 0.0641
2022-05-26 2022-03-31 NP Myriad Genetics EC US62855J1043 123,753 2,191 1.80 3,119 -7.06 0.0726
2022-02-25 2021-12-31 NP Myriad Genetics EC US62855J1043 121,562 3,445 2.92 3,355 -12.01 0.0728
2021-11-24 2021-09-30 NP Myriad Genetics EC US62855J1043 118,117 2,069 1.78 3,814 7.47 0.0840
2021-08-26 2021-06-30 NP Myriad Genetics EC US62855J1043 116,048 7,608 7.02 3,549 7.48 0.0761
2021-05-27 2021-03-31 NP Myriad Genetics EC US62855J1043 108,440 -5,091 -4.48 3,302 47.04 0.0749
2021-02-25 2020-12-31 NP Myriad Genetics EC US62855J1043 113,531 0 0.00 2,245 51.69 0.0575
2020-11-25 2020-09-30 NP Myriad Genetics EC US62855J1043 113,531 -7,307 -6.05 1,480 8.03 0.0475
2020-08-27 2020-06-30 NP Myriad Genetics EC US62855J1043 120,838 5,740 4.99 1,370 -16.82 0.0448
2020-06-01 2020-03-31 NP Myriad Genetics EC US62855J1043 115,098 5,713 5.22 1,647 -44.69 0.0673
2020-02-27 2019-12-31 NP Myriad Genetics EC 62855J104 109,385 1,560 1.45 2,979 -3.53 0.0896
2019-11-27 2019-09-30 NP Myriad Genetics EC US62855J1043 107,825 107,825 3,087 0.1020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.